高级检索
当前位置: 首页 > 详情页

Absorption characteristics of the total alkaloids from Mahonia bealei in an in situ single-pass intestinal perfusion assay.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 统计源期刊 ◇ CSCD-E

机构: [1]State Key Laboratory of Natural Medicines, China Pharmaceutical Universit, Nanjing 210009, China [2]School of pharmac, Nanjing University of Chinese Medicine, Nanjing 210000, China [3]Guangdong Provincial Key Laboratory of Pharmacodymamic Constituents of TCM and New Drugs Research, Jinan Universiny, Guangzhou 510632, China [4]The People's Hospital of Zhangqiu City, Zhangqiu 250200, China
出处:
ISSN:

摘要:
To investigate the absorption characteristics of the total alkaloids from Mahoniae Caulis (TAMC) through the administration of monterpene absorption enhancers or protein inhibitors. The absorption behavior was investigated in an in situ single-pass intestinal perfusion (SPIP) assay in rats. The intestinal absorption of TAMC was much more than that of a single compound or a mixture of compounds (jatrorrhizine, palmatine, and berberine). Promotion of absorption by the bicyclic monoterpenoids (borneol or camphor) was higher than by the monocyclic monoterpenes (menthol or menthone), and promotion by compounds with a hydroxyl group (borneol or menthol) was higher than those with a carbonyl group (camphor or menthone). The apparent permeability coefficient (Papp) of TAMC was increased to 1.8-fold by verapamil, while it was reduced to one half by thiamine. The absorption rate constant (Ka) and Papp of TAMC were unchanged by probenecid and pantoprazole. The intestinal absorption characteristics of TAMC might be passive transport, and the intestinum tenue was the best absorptive site. In addition, TAMC might be likely a substrate of P-glycoprotein (P-gp) and organic cation transporters (OCT), rather than multidrug resistance protein (MRP) and breast cancer resistance protein (BCRP). Compared with a single compound and a mixture of compounds, TAMC was able to be absorbed in the blood circulation effectively. Copyright © 2014 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 全科医学与补充医学 2 区 药学
第一作者:
第一作者机构: [1]State Key Laboratory of Natural Medicines, China Pharmaceutical Universit, Nanjing 210009, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号